https://hipa.ai/drug/semaglutide/updates/boxed-warning-present-label-ozempic-label-effective-2026-07-2026-07-30 Hipa.ai en 2026-07-30T00:00:00.000Z Ozempic Label Adds Boxed Warning for Thyroid C-Cell Tumors https://hipa.ai/drug/baxdrostat/updates/trial-results-posted-nct06034743-2026-07-30 Hipa.ai en 2026-07-30T00:00:00.000Z Baxdrostat Phase 3 Trial Shows Significant SBP Reduction in Resistant… https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02718066-2026-07-30 Hipa.ai en 2026-07-30T00:00:00.000Z Nivolumab Combination Trial Shows 56.6% ORR in Melanoma, Manageable Safety https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04576091-2026-07-29 Hipa.ai en 2026-07-29T00:00:00.000Z Pembrolizumab Combination for Recurrent Head & Neck Cancer: Phase 1 MTD of 10 mg https://hipa.ai/drug/tirzepatide/updates/boxed-warning-present-label-mounjaro-label-effective-2026-07-2026-07-29 Hipa.ai en 2026-07-29T00:00:00.000Z Mounjaro (Tirzepatide) Label Adds Boxed Warning for Thyroid C-Cell Tumors https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-07-29 Hipa.ai en 2026-07-29T00:00:00.000Z Metformin Hydrochloride Label Adds Boxed Warning for Lactic Acidosis https://hipa.ai/drug/canagliflozin/updates/boxed-warning-revised-metformin-hydrochloride-label-2026-07-28 Hipa.ai en 2026-07-28T00:00:00.000Z Metformin Hydrochloride Boxed Warning Revised for Lactic Acidosis Risk https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-07-28 Hipa.ai en 2026-07-28T00:00:00.000Z Metformin Hydrochloride Label Revised with Boxed Warning for Lactic Acidosis https://hipa.ai/drug/tofacitinib/updates/boxed-warning-revised-tofacitinib-label-effective-2026-07-27-2026-07-27 Hipa.ai en 2026-07-27T00:00:00.000Z Tofacitinib Boxed Warning Revised to Include Mortality, MACE, and Thrombosis https://hipa.ai/drug/liraglutide/updates/boxed-warning-revised-liraglutide-label-effective-2026-07-27-2026-07-27 Hipa.ai en 2026-07-27T00:00:00.000Z Liraglutide Boxed Warning Revised for Thyroid C-Cell Tumor Risk